BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kiakojuri K, Rajabnia R, Jalili B, Khafri S, Omran SM. Otomycosis in Adolescent Patients Referred to the Therapeutic Centers in Babol City, Iran. Jundishapur J Microbiol 2015;8:e17138. [PMID: 26060563 DOI: 10.5812/jjm.8(5)2015.17138] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Cheraghsahar S, Kazemi S, Birjandi M, Yarahmadi M, Mahmoudi S, Mohammadi R, Sepahvand A. Otomycosis in Western Iran: Clinical and Mycological Aspects. Arch Clin Infect Dis 2017;In Press. [DOI: 10.5812/archcid.57287] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Kiakojuri K, Rajabnia R, Mahdavi Omran S, Pournajaf A, Karami M, Taghizadeh Armaki M. Role of Clotrimazole in Prevention of Recurrent Otomycosis. Biomed Res Int 2019;2019:5269535. [PMID: 31950041 DOI: 10.1155/2019/5269535] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Ismail MT, Al-Kafri A, Ismail M. Otomycosis in Damascus, Syria: Etiology and clinical features. Curr Med Mycol 2017;3:27-30. [PMID: 29707671 DOI: 10.29252/cmm.3.3.27] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
4 Kiakojuri K, Armaki MT, Rajabnia R, Pournajaf A, Karami M, Khademian A, Omran SM. Outer Ear Infections in Iran: A Review. Open Access Maced J Med Sci 2019;7:1233-40. [PMID: 31049113 DOI: 10.3889/oamjms.2019.176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
5 Gharaghani M, Halvaeezadeh M, Ali Jalaee G, Taghipour S, Kiasat N, Zarei Mahmoudabadi A. Antifungal susceptibility profiles of otomycosis etiological agents in Ahvaz, Iran. Curr Med Mycol 2020;6:18-22. [PMID: 33628977 DOI: 10.18502/CMM.6.2.2696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Aboutalebian S, Mahmoudi S, Mirhendi H, Okhovat A, Abtahi H, Chabavizadeh J. Molecular epidemiology of otomycosis in Isfahan revealed a large diversity in causative agents. J Med Microbiol 2019;68:918-23. [PMID: 31063125 DOI: 10.1099/jmm.0.000985] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
7 Gharaghani M, Seifi Z, Zarei Mahmoudabadi A. Otomycosis in iran: a review. Mycopathologia 2015;179:415-24. [PMID: 25633436 DOI: 10.1007/s11046-015-9864-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
8 Kamali Sarwestani Z, Hashemi SJ, Rezaie S, Gerami Shoar M, Mahmoudi S, Elahi M, Bahardoost M, Tajdini A, Abutalebian S, Daie Ghazvini R. Species identification and in vitro antifungal susceptibility testing of Aspergillus section Nigri strains isolated from otomycosis patients. J Mycol Med 2018;28:279-84. [PMID: 29540288 DOI: 10.1016/j.mycmed.2018.02.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]